Design, Synthesis, enzyme inhibitory activity and molecular docking studies of new 1,2,3-triazole linked nucleobases
Thirteen novel 1,2,3-triazole linked nucleobases (5a-m) were designed and efficiently synthesized as potential human enzyme inhibitors. The target compounds were synthesized by using Copper (I)-catalysed Huisgen-Sharpless-Meldal 1,3-dipolar cycloaddition reaction of propargylated nucleobases and sub...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Results in Chemistry |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211715624007070 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Thirteen novel 1,2,3-triazole linked nucleobases (5a-m) were designed and efficiently synthesized as potential human enzyme inhibitors. The target compounds were synthesized by using Copper (I)-catalysed Huisgen-Sharpless-Meldal 1,3-dipolar cycloaddition reaction of propargylated nucleobases and substituted aryl azides in good yield. Compounds (5a-m) were characterized by their 1HNMR, 13C NMR, 2D NMR and mass spectral data. All compounds were screened in vitro for their inhibitory efficacy against pepsin, trypsin, lipase and α-amylase enzymes. All the compounds showed more than 50 % inhibition against these enzymes. Interestingly, four compounds, including 5d, 5h, 5k and 5m displayed excellent potent level of enzyme inhibitory activity at 10−7 M concentration. Further, molecular docking analysis revealed that some compounds shown significant binding interactions with target sites. Compound 5h exhibited the highest enzyme inhibitory activity (trypsin, % inhibition = 81.55) at 10−7 M concentration in comparison to the reference drug orlistat. |
|---|---|
| ISSN: | 2211-7156 |